file,ref_number,ref_text,doi,doi_url,titleDoi,firstAuthDoi,author_similarity,title_similarity
experiments/mouse_immunology/ai_messages/high_complexity--YUMM_1_7,[1],"Meeth K, Wang JX, Micevic G, Damsky W, Bosenberg MW. 2016. The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations. Pigment Cell Melanoma Res. 29(5):590-7.",10.1111/pcmr.12498,https://doi.org/10.1111/pcmr.12498,The <scp>YUMM</scp> lines: a series of congenic mouse melanoma cell lines with defined genetic alterations,Meeth,100,98
experiments/mouse_immunology/ai_messages/high_complexity--YUMM_1_7,[2],National Cancer Institute. 2021. Melanoma Treatment (PDQ®)–Patient Version. https://www.cancer.gov/types/skin/patient/melanoma-treatment-pdq,10.1093/jnci/96.18.1355,https://doi.org/10.1093/jnci/96.18.1355,"Stat Bite: Treatment Trials in the PDQ Clinical Trials Database, by Phase",,0,48
experiments/mouse_immunology/ai_messages/high_complexity--YUMM_1_7,[3],"Vinay DS, Ryan EP, Pawelec G, Talib WH, Stagg J, Elkord E, Lichtor T, Decker WK, Whelan RL, Kumara HMCS, Signori E, Honoki K, Georgakilas AG, Amin A, Helferich WG, Boosani CS, Guha G, Ciriolo MR, Chen S, Mohammed SI, Azmi AS, Keith WN, Bilsland A, Bhakta D, Halicka D, Fujii H, Aquilano K, Ashraf SS, Nowsheen S, Yang X, Choi BK, Kwon BS. 2015. Immune evasion in cancer: Mechanistic basis and therapeutic strategies. Semin Cancer Biol. 35 Suppl:S185-S198.",10.1016/j.semcancer.2015.03.004,https://doi.org/10.1016/j.semcancer.2015.03.004,Immune evasion in cancer: Mechanistic basis and therapeutic strategies,Vinay,100,100
